Aby Joseph | Genetics and Genomics | Best Researcher Award

Published on by Forensic Scientist

Dr. Aby Joseph | Genetics and Genomics | Best Researcher Award

Amity University, Dubai | United Arab Emirates

Dr. Aby Joseph is a distinguished forensic science scholar whose research has significantly advanced forensic DNA quality management, crime scene biology, and international forensic accreditation systems. His work focuses on enhancing the accuracy and integrity of forensic DNA workflows through contamination control strategies, DNA quality improvement models, and ISO/IEC 17025–aligned quality frameworks. Notably, his Scopus-indexed scholarly footprint includes 7 publications, 3 citations, and an h-index of 1, reflecting a steadily growing impact in the forensic science research community. Dr. Aby Joseph has authored influential peer-reviewed articles in leading journals such as the Journal of Forensic Science and Medicine, Problems of Forensic Science, Multidisciplinary Science Journal, and the Journal of Communicable Diseases. His research spans integrated ISO-centric quality systems, comparative analyses of national forensic DNA frameworks, contamination mitigation, and forensic interventions in zoonotic disease transmission. In addition to journal publications, he has contributed book chapters with Nova Science Publishers and Springer, covering forensic entomology and advanced investigative methodologies. His scholarly presence is further strengthened by case studies, conference papers, and invited presentations on topics such as GCC forensic DNA standard harmonization, parentage testing complexities, disaster victim identification, wildlife crime, and advancements in forensic genetics. As a keynote speaker, session chair, and panel moderator at major international conferences, he has demonstrated notable academic leadership. Dr. Aby Joseph’s research contributions continue to shape forensic quality assurance, DNA analysis standards, and evidence-based forensic innovation worldwide.

Profiles: Scopus | ORCID

Featured Publications

  • Joseph, A., Rao, I., & Singh, N. (2025). Contamination control and quality assurance in forensic DNA analysis: Lessons from the UK and Indian system. Journal of Forensic Science and Medicine, 11(3), 163–169.

  • Joseph, A. (2024). Enhancing forensic DNA quality: A comprehensive review of integrated ISO-centric standards from the crime scene to the courtroom. Problems of Forensic Science.

  • Joseph, A. (2025). Towards standardized forensic DNA practices: Comparative analysis of forensic DNA quality management systems in India and the UK. Multidisciplinary Science Journal.

Mehrdad Hashemi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist

Prof. Mehrdad Hashemi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Tehran Medical Sciences, Islamic Azad University | Iran

Professor Mehrdad Hashemi is a renowned scholar in Molecular and Medical Genetics whose pioneering research has made transformative contributions to predictive, preventive, and personalized medicine. His scientific work focuses on the discovery of diagnostic and therapeutic biomarkers particularly non-coding RNAs (lncRNAs and miRNAs) with profound implications for early disease detection, molecular targeting, and precision therapy. Prof. Mehrdad Hashemi has authored 372 peer-reviewed publications indexed in Scopus, accumulating over 6,826 citations from 6,242 documents, and achieving a remarkable h-index of 41. His research portfolio includes 299 ISI-indexed papers, 342 Scopus-indexed papers, and 258 PubMed articles, encompassing 119 Q1 and 82 Q2 journals. He has led or completed 14 major research projects, contributed to 95 industrial and academic collaborations, and maintained 110 international research partnerships with leading institutions across the USA, UK, Canada, China, Germany, Australia, and beyond. His scholarly output also includes 3 internationally published books and 1 patent. Ranked among the World’s Top 1% and 2% Scientists in both ESI (2024) and Stanford (2024–2025) global rankings, Prof. Mehrdad Hashemi’s groundbreaking studies on exosomes, nanomedicine, gene regulation, and cancer therapeutics have advanced global understanding of disease mechanisms and innovative treatment modalities. He also contributes extensively as an editorial board member, peer reviewer, and thought leader in the field of molecular diagnostics and translational genetics.

Profiles: Scopus | Google Scholar | ORCID | Staff Page

Featured Publications

  • Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., … & Hashemi, M. (2022). Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. Journal of Hematology & Oncology, 15(1), 83. https://doi.org/10.1186/s13045-022-01296-0

  • Bolhassani, A., Javanzad, S., Saleh, T., Hashemi, M., Aghasadeghi, M. R., … & Sadat, S. M. (2014). Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases. Human Vaccines & Immunotherapeutics, 10(2), 321–332. https://doi.org/10.4161/hv.26796

  • Entezari, M., Hashemi, D., Taheriazam, A., Zabolian, A., Mohammadi, S., … & Hashemi, M. (2022). AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation. Biomedicine & Pharmacotherapy, 146, 112563. https://doi.org/10.1016/j.biopha.2021.112563

  • Hashemi, M., Moosavi, M. S., Abed, H. M., Dehghani, M., Aalipour, M., Heydari, E. A., … & Mirzaei, S. (2022). Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacological Research, 184, 106418. https://doi.org/10.1016/j.phrs.2022.106418

  • Sadrkhanloo, M., Entezari, M., Orouei, S., Ghollasi, M., Rezaei, S., Hejazi, E. S., … & Hashemi, M. (2022). STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response. Pharmacological Research, 182, 106311. https://doi.org/10.1016/j.phrs.2022.106311

Hamid Zaferani Arani | Biology | Best Researcher Award

Published on by Forensic Scientist

Dr. Hamid Zaferani Arani | Biology | Best Researcher Award

Department of Surgery, Shiraz University of Medical Sciences | Iran

Dr. Hamid Zaferani Arani is an accomplished Iranian Medical Doctor (M.D.) and President of the knowledge-based company Ideh Pardazan Teb Gostar. A prolific researcher in oncology, neuroscience, and regenerative medicine, he has authored numerous publications, books, and patents. Recognized as a top national medical student (2021), his work spans clinical studies, biomedical innovation, and medical education.

Professional profile👤

ORCID

Google Scholar

Scopus

Strengths for the Awards✨

  1. Extensive Research Output

    • Dr. Arani has a prolific publication record, with multiple peer-reviewed articles in reputable journals, including Plos One, Oxidative Medicine and Cellular Longevity, and Journal of Cancer Research and Therapeutics.

    • His research spans cancer biology, neuroscience, regenerative medicine, and clinical medicine, demonstrating multidisciplinary expertise.

  2. Academic and Professional Leadership

    • President of a knowledge-based medical equipment company, indicating applied research and innovation in medical technology.

    • Active involvement in research centers (Cognitive and Neuroscience Research Center, Cancer Research Center) and professional associations (Iran’s National Elites Foundation).

  3. Conference Participation and Recognition

    • Invited speaker and board member at multiple international and national conferences (e.g., LIMSC in the Netherlands, International Breast Cancer Congress).

    • Recipient of numerous awards, including “Distinctive Researcher” (2016-2021) and “Top Student in Medicine in Iran” (2021).

  4. Innovation and Patents

    • Holds multiple patents, including medical devices and therapeutic formulations (e.g., oral medicine for neonatal jaundice, hearing aid technology).

    • Demonstrates translational research impact, bridging laboratory findings with clinical and industrial applications.

Education 🎓

  • M.D. (2014–2021): Faculty of Medicine, Islamic Azad University, Tehran Medical Sciences.

  • Research Training: Cognitive Neuroscience (CNRC), Cancer Research Center (Shahid Beheshti University), and international workshops in Leiden, Netherlands (2017) on medical statistics, publishing, and innovation.

Experience 💼

  • President: Ideh Pardazan Teb Gostar (Dayan ATA MEDICA), leading R&D in medical equipment.

  • Researcher: Collaborated with Shahid Beheshti University on breast cancer studies (2016–2021).

  • Educator: Taught medical statistics, scientific writing, and research methodology at Islamic Azad University.

Research Interests On Biology 🔬

  • Cancer Biology: Biomarkers, breast cancer, and therapeutic agents (e.g., Hypericin, Naringenin).

  • Neuroscience: Cerebral ischemia, neuroprotection, and drug effects (e.g., FK506, Atorvastatin).

  • Regenerative Medicine: Scaffold engineering, wound healing, and amniotic membrane applications.

Awards & Honors 🏆

  • Top National Medical Student (2021)

  • Distinctive Researcher (2016–2020, Islamic Azad University)

  • Best Startup Idea (2019, ITEM Weekend)

  • Top Speaker at LIMSC (Leiden, 2017)

Publications 📜

  • Title: EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
    Authors: M Hashemi, HZ Arani, S Orouei, S Fallah, A Ghorbani, M Khaledabadi, …
    Year: 2022
    Citations: 115

  • Title: Hydrogels based on cellulose and its derivatives: applications, synthesis, and characteristics
    Authors: S Ghorbani, H Eyni, SR Bazaz, H Nazari, LS Asl, H Zaferani, V Kiani, …
    Year: 2018
    Citations: 60

  • Title: Verapamil Inhibits Mitochondria‐Induced Reactive Oxygen Species and Dependent Apoptosis Pathways in Cerebral Transient Global Ischemia/Reperfusion
    Authors: E Jangholi, ZN Sharifi, M Hoseinian, MR Zarrindast, HR Rahimi, A Mowla, …
    Year: 2020
    Citations: 44

  • Title: Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study
    Authors: H Zaferani Arani, G Dehghan Manshadi, HA Atashi, A Rezaei Nejad, …
    Year: 2021
    Citations: 30

  • Title: Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
    Authors: M Hashemi, HZ Arani, S Orouei, E Rostamnejad, A Ghorbani, …
    Year: 2022
    Citations: 21

  • Title: Cyanidin 3-glycoside induced apoptosis in MCF-7 breast cancer cell line
    Authors: SA Mirmalek, S Faraji, S Ranjbaran, H Aryan, HZ Arani, E Jangholi, …
    Year: 2020
    Citations: 15

  • Title: A comparative study on effective factors in patient safety culture from the nursing staff points of view
    Authors: K Alimohammadzadeh, S Esmaili Joladi, M Olya, A Ghaiyoomi, …
    Year: 2017
    Citations: 15

  • Title: Comparing the effects of oleoresin of Pistacia atlantica tree and diclofenac gel on the knee osteoarthritis improvement
    Authors: M Peivastegan, M Rajabi, HZ Arani, M Olya, HA Atashi, S Abolghasemi
    Year: 2020
    Citations: 12

  • Title: Knowledge, attitudes, and practices toward breast cancer: among midwives in a breast cancer educational seminar in Tehran
    Authors: HA Atashi, ME Vaghar, M Olya, P Mirzamohammadi, HZ Arani, …
    Year: 2020
    Citations: 9

  • Title: Effect of topical Areca palm L. hydroalcoholic extract on burn wound healing in rats
    Authors: Z Abbasy, AA Tameh, R Mozaffari-Kermani, HZ Arani, SA Talaei
    Year: 2021
    Citations: 7

Conclusion 🌟

Dr. Zaferani Arani exemplifies translational research, bridging clinical medicine with innovation. His leadership in knowledge-based enterprises, coupled with 50+ publications and 10+ patents, underscores his commitment to advancing healthcare. A dynamic educator and researcher, he continues to explore frontiers in cancer therapy, neuroprotection, and medical technology.